CeQur is a series c plus startup. 1 investor tracked.
CeQur is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
CeQur develops and commercializes simple-to-use insulin delivery systems that empower people living with diabetes. Its simple, three-day, wearable devices provide discreet and convenient insulin delivery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.